Correction:Efficacy of Intravenous Treprostinil in High-Risk Single Ventricle Patients Undergoing Glenn ProcedureOA
In the article“Efficacy of Intravenous Treprostinil in High-Risk Single Ventricle Patients Undergoing Glenn Procedure”by Xiaofeng Wang,Xingwei Chen,Shilin Wang,Xia Li,Zhongyuan Lu,Wenlong Wang,Xu Wang(Congenital Heart Disease,2024,vol.19,no.5,pp.489-498.DOI:10.32604/chd.2024.054441,URL:https://www.techscience.com/chd/v19n5/59166).
Xiaofeng Wang;Xingwei Chen;Shilin Wang;Xia Li;Zhongyuan Lu;Wenlong Wang;Xu Wang
Department of Pediatric Intensive Care Unit,National Center for Cardiovascular Disease,Fuwai Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,100037,ChinaDepartment of Pharmacy,National Center for Cardiovascular Disease,Fuwai Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,100037,ChinaDepartment of Pediatric Intensive Care Unit,National Center for Cardiovascular Disease,Fuwai Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,100037,ChinaDepartment of Pediatric Intensive Care Unit,National Center for Cardiovascular Disease,Fuwai Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,100037,ChinaDepartment of Pediatric Intensive Care Unit,National Center for Cardiovascular Disease,Fuwai Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,100037,ChinaDepartment of Pediatric Intensive Care Unit,National Center for Cardiovascular Disease,Fuwai Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,100037,ChinaDepartment of Pediatric Intensive Care Unit,National Center for Cardiovascular Disease,Fuwai Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,100037,China
医药卫生
intravenous treprostinilglenn procedurehigh risk single ventricle patientsGlenn procedure
《Congenital Heart Disease》 2025 (3)
P.401-402,2
评论